Skip to content

Efavirenz, Kaletra and boosted atazanavir reduce levels of key anti-malaria drug

Weight gain after starting ART predicts survival

Drug-resistant TB now at record levels, says WHO

Aciclovir shows lower efficacy outside US in global trial

Over a third of TB cases in UK prisons are drug-resistant

'Test and treat' prevention approach may not require universal treatment to succeed

High prevalence of drug-resistant TB amongst HIV patients in South Africa

Genital ulcers frequently associated with HIV shedding in men

HIV biggest cause of adolescent death and hospitalisation in Zimbabwe